Por favor, tente outra pesquisa
Nome | Idade | Desde | Título |
---|---|---|---|
Masayoshi Takeda | - | 2022 | GM, Head of Finance & Accounting Department and Full-Time Audit & Supervisory Board Member |
Naoyuki Mochida | - | 1999 | President & Representative Director |
Kyosuke Wagai | - | 2016 | Outside Audit & Supervisory Board Member |
Keiichi Sagisaka | - | 2010 | Senior Executive Managing Officer of Pharmaceutical Business & Healthcare and Director |
Tomoo Kugisawa | - | 2012 | Independent Outside Director |
Kiyoshi Mizuguchi | - | 2015 | Exec Managing Officer of Research & Development, Supervisor of Pharmaceutical Plant and Director |
Yutaka Kawakami | - | 2019 | Executive Managing Officer, Executive Officer, Head of RA, QA & PV and Executive Director |
Junichi Sakaki | - | 2014 | Senior Exec Managing Officer of Business Development, Supervisor of Biomaterials Business & Director |
Yoshiharu Hashimoto | - | 2019 | Full-Time Audit & Supervisory Board Member |
Yoshifumi Miyata | - | 2021 | Outside Audit & Supervisory Board Member |
Nana Otsuki | - | 2021 | Independent Outside Director |
Shigeaki Yoshikawa | - | 2023 | Independent Outside Director |
Akiko Suzuki | - | 2019 | Outside Audit & Supervisory Board Member |
Tomoaki Sonoda | - | 2022 | Independent Outside Director |
Motoi Mitsuishi | - | 2023 | Member of the Board & Executive Managing Officer |
Chu Sakata | - | 2011 | Senior EVP & Representative Director |
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou deste comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão